Contact
CoCalc Logo Icon
StoreFeaturesDocsShareSupportNewsAboutSign UpSign In
| Download

edX - TXT1x Data

Views: 8542
1
<SEC-DOCUMENT>0000897101-01-500678.txt : 20011030
2
<SEC-HEADER>0000897101-01-500678.hdr.sgml : 20011030
3
ACCESSION NUMBER: 0000897101-01-500678
4
CONFORMED SUBMISSION TYPE: 10-K/A
5
PUBLIC DOCUMENT COUNT: 2
6
CONFORMED PERIOD OF REPORT: 20010427
7
FILED AS OF DATE: 20011026
8
9
FILER:
10
11
COMPANY DATA:
12
COMPANY CONFORMED NAME: MEDTRONIC INC
13
CENTRAL INDEX KEY: 0000064670
14
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
15
IRS NUMBER: 410793183
16
STATE OF INCORPORATION: MN
17
FISCAL YEAR END: 0430
18
19
FILING VALUES:
20
FORM TYPE: 10-K/A
21
SEC ACT: 1934 Act
22
SEC FILE NUMBER: 001-07707
23
FILM NUMBER: 1767021
24
25
BUSINESS ADDRESS:
26
STREET 1: 710 MEDTRONIC PKWY
27
STREET 2: MS LC300
28
CITY: MINNEAPOLIS
29
STATE: MN
30
ZIP: 55432
31
BUSINESS PHONE: 7635144000
32
</SEC-HEADER>
33
<DOCUMENT>
34
<TYPE>10-K/A
35
<SEQUENCE>1
36
<FILENAME>medtronic014265_10ka.htm
37
<DESCRIPTION>MEDTRONIC, INC. FORM 10-K/A
38
<TEXT>
39
<HTML>
40
<HEAD>
41
<!-- Control Number: 014265 -->
42
<!-- Rev Number: 1.0 -->
43
<!-- Client Name: Medtronic, Inc. -->
44
<!-- Project Name: Form 10-K/A -->
45
<!-- Firm Name: Medtronic, Inc. -->
46
<TITLE>Medtronic, Inc. Form 10-K/A</TITLE>
47
</HEAD>
48
<BODY>
49
50
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
51
<P ALIGN="CENTER"><B>FORM 10-K/A<BR>(AMENDMENT NO. 1) <BR>SECURITIES AND EXCHANGE COMMISSION
52
<BR>Washington, D.C. 20549</B></P>
53
54
<!-- MARKER FORMAT-SHEET="Para Cutoff Rule" -->
55
<HR SIZE=1 WIDTH=15% ALIGN=CENTER>
56
57
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
58
<P><FONT SIZE=3>Amendment No. 1 to annual report pursuant to Section 13 or 15(d) of the<BR>
59
Securities Act of 1934 for the fiscal year ended April 27, 2001. </FONT></P>
60
61
<!-- MARKER FORMAT-SHEET="Para Center" -->
62
<P ALIGN="CENTER">Commission File No. 1-7707</P>
63
64
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
65
<P ALIGN="CENTER"><B>MEDTRONIC, INC.</B></P>
66
67
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" ALIGN="CENTER" WIDTH="600">
68
<TR VALIGN="BOTTOM">
69
<TD WIDTH="52%" ALIGN="CENTER">Minnesota</TD>
70
<TD WIDTH="48%" ALIGN="CENTER">41-0793183</TD></TR>
71
<TR VALIGN="BOTTOM">
72
<TD ALIGN="CENTER">(State of Incorporation)</TD>
73
<TD ALIGN="CENTER">(I.R.S. Employer Identification No.)</TD></TR>
74
</TABLE>
75
76
77
<!-- MARKER FORMAT-SHEET="Para Center" -->
78
<P ALIGN="CENTER">710 Medtronic Parkway <BR>Minneapolis, Minnesota 55432 <BR>(Address of
79
principal executive offices)
80
<BR>Telephone number: (763) 514-4000</P>
81
82
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
83
<P><FONT SIZE=3>The undersigned registrant hereby amends Part IV, Item 14(a)3, entitled
84
&#147;Exhibits&#148;, of its Annual Report on Form 10-K for fiscal 2001 to add the
85
following exhibits: </FONT></P>
86
87
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
88
<P><FONT SIZE="3"><U>Exhibit No.</U></FONT> </P>
89
90
91
92
<!-- MARKER FORMAT-SHEET="Para Hang" -->
93
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
94
<TR VALIGN=TOP>
95
<TD WIDTH=10%><FONT SIZE=3>99.1 </FONT></TD>
96
<TD WIDTH=90%><FONT SIZE=3>Form
97
11-K for the Medtronic, Inc. and Participating Employers Supplemental Retirement Plan for
98
the year ended April 30, 2001.</FONT></TD>
99
</TR>
100
</TABLE>
101
<BR>
102
103
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
104
<P><FONT SIZE=3>Pursuant to the requirements of Section 13 or 15(d) of the Securities
105
Exchange Act of 1934, the registrant has duly caused this amendment to be signed on its
106
behalf by the undersigned, thereunto duly authorized. </FONT></P>
107
<BR>
108
109
110
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" ALIGN="CENTER" WIDTH="100%">
111
<TR VALIGN="BOTTOM">
112
<TD WIDTH="50%" ALIGN="LEFT">&nbsp;&nbsp;</TD>
113
<TD WIDTH="50%" ALIGN="LEFT"><B>MEDTRONIC, INC.</B></TD></TR>
114
<TR VALIGN="BOTTOM">
115
<TD WIDTH="50%" ALIGN="LEFT">&nbsp;</TD>
116
<TD WIDTH="50%" ALIGN="LEFT">&nbsp;</TD></TR>
117
<TR VALIGN="BOTTOM">
118
<TD ALIGN="LEFT">Dated:&nbsp;&nbsp;October 25, 2001<BR>&nbsp;<BR>&nbsp;</TD>
119
<TD ALIGN="LEFT">By: <U>/s/ Arthur D. Collins, Jr.</U><BR>Arthur D. Collins, Jr., President<BR>and Chief Executive Officer
120
</TD></TR>
121
</TABLE>
122
123
124
125
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
126
<P ALIGN="CENTER">&nbsp;</P>
127
128
129
130
131
132
<!-- *************************************************************************** -->
133
<!-- MARKER PAGE="sheet: 1; page: 1" -->
134
135
136
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
137
<P ALIGN="CENTER"><B>INDEX OF EXHIBITS</B></P>
138
139
140
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
141
<P><FONT SIZE="3"><U>EXHIBITS</U></FONT> </P>
142
<BR>
143
144
<!-- MARKER FORMAT-SHEET="Para Hang" -->
145
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
146
<TR VALIGN=TOP>
147
<TD WIDTH=10%><FONT SIZE=3>99.1 </FONT></TD>
148
<TD WIDTH=90%><FONT SIZE=3>Form
149
11-K for the Medtronic, Inc. and Participating Employers Supplemental Retirement Plan for
150
the year ended April 30, 2001.</FONT></TD>
151
</TR>
152
</TABLE>
153
<BR>
154
155
</BODY>
156
</HTML>
157
158
</TEXT>
159
</DOCUMENT>
160
<DOCUMENT>
161
<TYPE>EX-99.1
162
<SEQUENCE>3
163
<FILENAME>medtronic014265_ex99-1.htm
164
<DESCRIPTION>FORM 11-K FOR MEDTRONIC
165
<TEXT>
166
<HTML>
167
<HEAD>
168
<TITLE>Medtronic, Inc. Exhibit 99.1</TITLE>
169
</HEAD>
170
<BODY>
171
172
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
173
<P ALIGN="CENTER"><B>EXHIBIT 99.1</B></P>
174
<BR><BR>
175
176
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
177
<P ALIGN="CENTER"><B>SECURITIES AND EXCHANGE COMMISSION<BR>Washington, D.C. 20549</B></P>
178
179
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
180
<P ALIGN="CENTER"><B>FORM 11-K</B></P>
181
182
<TABLE WIDTH=90% CELLPADDING=0 CELLSPACING=0 BORDER=0>
183
<TR VALIGN="TOP">
184
<TD WIDTH="100%" COLSPAN=2 ALIGN="LEFT">(mark one)</TD></TR>
185
<TR VALIGN="TOP">
186
<TD ALIGN="LEFT" WIDTH=5%>(X)</TD>
187
<TD ALIGN="LEFT" WIDTH=95%>ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE
188
SECURITIES EXCHANGE<BR> ACT OF 1934<BR>
189
For the fiscal year ended April 27, 2001</TD></TR>
190
<TR VALIGN="TOP">
191
<TD>&nbsp;</TD>
192
<TD ALIGN="CENTER">&nbsp;<BR>Or<BR>&nbsp;</TD></TR>
193
<TR VALIGN="TOP">
194
<TD ALIGN="LEFT">(&nbsp;&nbsp;)</TD>
195
<TD ALIGN="LEFT">TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES<BR>
196
EXCHANGE ACT OF 1934</TD></TR>
197
</TABLE>
198
199
<!-- MARKER FORMAT-SHEET="Para Center" -->
200
<P ALIGN="CENTER">Commission File Nos.:&nbsp;&nbsp;33-37529 and 33-44230</P>
201
202
<!-- MARKER FORMAT-SHEET="Para Hang" -->
203
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
204
<TR VALIGN=TOP>
205
<TD WIDTH=5%><FONT SIZE=3>A. </FONT></TD>
206
<TD WIDTH=95%><FONT SIZE=3>Full
207
title of the plan and the address of the plan, if different from that of the issuer named
208
below:</FONT></TD>
209
</TR>
210
</TABLE>
211
<BR>
212
213
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
214
<P ALIGN="CENTER"><B>MEDTRONIC, INC. AND PARTICIPATING EMPLOYERS<BR> SUPPLEMENTAL RETIREMENT
215
PLAN</B></P>
216
217
<!-- MARKER FORMAT-SHEET="Para Hang" -->
218
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
219
<TR VALIGN=TOP>
220
<TD WIDTH=5%><FONT SIZE=3>B. </FONT></TD>
221
<TD WIDTH=95%><FONT SIZE=3>Name
222
of issuer of the securities held pursuant to the plan and the address of its principal
223
executive office:</FONT></TD>
224
</TR>
225
</TABLE>
226
<BR>
227
228
<!-- MARKER FORMAT-SHEET="Para Center" -->
229
<P ALIGN="CENTER">Medtronic, Inc.<BR>710 Medtronic Parkway<BR>Minneapolis, MN 55432</P>
230
<BR><BR><BR>
231
232
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
233
<P ALIGN="CENTER"><B>SIGNATURES</B></P>
234
235
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
236
<P><FONT SIZE=3><I>The Plan. </I>Pursuant to the requirements of the Securities
237
Exchange Act of 1934, the trustees (or other persons who administer the employee
238
benefit plan) have duly caused this annual report to be signed on its behalf by
239
the undersigned hereunto duly authorized. </FONT></P>
240
241
242
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" ALIGN="CENTER" WIDTH="100%">
243
<TR VALIGN="BOTTOM">
244
<TD WIDTH="50%" ALIGN="LEFT">&nbsp;&nbsp;</TD>
245
<TD WIDTH="50%" ALIGN="LEFT"><B>MEDTRONIC, INC. AND PARTICIPATING<BR>
246
EMPLOYERS SUPPLEMENTAL RETIREMENT<BR> PLAN</B><BR>&nbsp;</TD></TR>
247
248
<TR VALIGN="TOP">
249
<TD ALIGN="LEFT">Dated:&nbsp;&nbsp;October 25, 2001</TD>
250
<TD>By: &nbsp;&nbsp;<U>/s/ Janet S. Fiola</U><BR>
251
252
<BLOCKQUOTE>Janet S. Fiola<BR>
253
Senior Vice President,<BR>
254
Human Resources</BLOCKQUOTE></TD></TR>
255
</TABLE>
256
257
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
258
<P ALIGN="CENTER">&nbsp;</P>
259
260
261
262
263
264
<PAGE>
265
266
267
<BR>
268
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
269
<P><FONT SIZE="5"><B>Medtronic, Inc. and<BR>Participating Employers<BR>
270
Supplemental Retirement Plan</B></FONT> </P>
271
272
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
273
<P><FONT SIZE="3"><B>Financial Statements and Supplemental Schedule<BR>
274
April 30, 2001 and 2000</B></FONT> </P>
275
276
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
277
<P ALIGN="CENTER">&nbsp;</P>
278
279
280
281
282
283
<PAGE>
284
285
286
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
287
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>
288
Retirement Plan<BR>Index to Financial Statements</B></FONT> </P>
289
290
<HR SIZE=2 WIDTH=100%>
291
<BR>
292
293
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
294
<TR VALIGN="TOP">
295
<TD WIDTH="90%" ALIGN="LEFT">&nbsp;</TD>
296
<TD WIDTH="10%" ALIGN="RIGHT"><B>Page(s)</B></TD></TR>
297
<TR VALIGN="TOP">
298
<TD ALIGN="LEFT">&nbsp;</TD></TR>
299
<TR VALIGN="TOP">
300
<TD ALIGN="LEFT">Report of Independent Accountants</TD>
301
<TD ALIGN="CENTER">1</TD></TR>
302
<TR VALIGN="TOP">
303
<TD ALIGN="LEFT">&nbsp;</TD></TR>
304
<TR VALIGN="TOP">
305
<TD ALIGN="LEFT">Financial Statements:</TD></TR>
306
<TR VALIGN="TOP">
307
<TD ALIGN="LEFT">&nbsp;</TD></TR>
308
<TR VALIGN="TOP">
309
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Statement of Net Assets Available for Benefits</TD>
310
<TD ALIGN="CENTER">2</TD></TR>
311
<TR VALIGN="TOP">
312
<TD ALIGN="LEFT">&nbsp;</TD></TR>
313
<TR VALIGN="TOP">
314
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Statement of Changes in Net Assets Available for Benefits</TD>
315
<TD ALIGN="CENTER">3</TD></TR>
316
<TR VALIGN="TOP">
317
<TD ALIGN="LEFT">&nbsp;</TD></TR>
318
<TR VALIGN="TOP">
319
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Notes to Financial Statements</TD>
320
<TD ALIGN="CENTER">4-10</TD></TR>
321
<TR VALIGN="TOP">
322
<TD ALIGN="LEFT">&nbsp;</TD></TR>
323
<TR VALIGN="TOP">
324
<TD ALIGN="LEFT">Supplemental Schedule:</TD></TR>
325
<TR VALIGN="TOP">
326
<TD ALIGN="LEFT">&nbsp;</TD></TR>
327
<TR VALIGN="TOP">
328
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Schedule of Assets Held for Investment Purposes</TD>
329
<TD ALIGN="CENTER">12</TD></TR>
330
</TABLE>
331
<BR>
332
333
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
334
<P ALIGN="CENTER">&nbsp;</P>
335
336
337
338
339
340
341
342
<PAGE>
343
344
345
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
346
<P ALIGN="CENTER"><B>Report of Independent Accountants</B></P>
347
<BR><BR>
348
349
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
350
<P><FONT SIZE=3>To the Participants and Administrator of the<BR>
351
Medtronic, Inc. and Participating Employers<BR>
352
Supplemental Retirement Plan: </FONT></P>
353
354
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
355
<P><FONT SIZE=3>In our opinion, the accompanying statements of net assets available for
356
benefits and the related statements of changes in net assets available for benefits
357
present fairly, in all material respects, the net assets available for benefits of the
358
Medtronic, Inc. and Participating Employers Supplemental Retirement Plan (the &#147;Plan&#148;)
359
at April&nbsp;30, 2001 and 2000, and the changes in net assets available for benefits for the
360
years then ended in conformity with accounting principles generally accepted in the
361
United States of America. These financial statements are the responsibility of the Plan&#146;s
362
management; our responsibility is to express an opinion on these financial statements
363
based on our audits. We conducted our audits of these statements in accordance with
364
auditing standards generally accepted in the United States of America, which require that
365
we plan and perform the audit to obtain reasonable assurance about whether the financial
366
statements are free of material misstatement. An audit includes examining, on a test
367
basis, evidence supporting the amounts and disclosures in the financial statements,
368
assessing the accounting principles used and significant estimates made by management,
369
and evaluating the overall financial statement presentation. We believe that our audits
370
provide a reasonable basis for our opinion. </FONT></P>
371
372
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
373
<P><FONT SIZE=3>Our audits were conducted for the purpose of forming an opinion on the
374
basic financial statements taken as a whole. The supplemental schedule of Assets Held For
375
Investment Purposes is presented for the purpose of additional analysis and is not a
376
required part of the basic financial statements but is supplementary information required
377
by the Department of Labor&#146;s Rules and Regulations for Reporting and Disclosure
378
under the Employee Retirement Income Security Act of 1974. This supplemental schedule is
379
the responsibility of the Plan&#146;s management. The supplemental schedule has been
380
subjected to the auditing procedures applied in the audits of the basic financial
381
statements and, in our opinion, is fairly stated in all material respects in relation to
382
the basic financial statements taken as a whole. </FONT></P>
383
384
385
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
386
<P><FONT SIZE=3>As discussed in Note 1, subsequent to April 30, 2001, the Plan was merged
387
into the Medtronic, Inc. Employee Stock Ownership and Supplemental Retirement Plan and all Plan
388
assets and related benefit obligations were transferred at that date. </FONT></P>
389
<BR><BR><BR>
390
391
392
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
393
<P><FONT SIZE=3>Minneapolis, Minnesota<BR>
394
September 28, 2001 </FONT></P>
395
<BR><BR>
396
397
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
398
<P ALIGN="CENTER">1</P>
399
400
401
402
<PAGE>
403
404
405
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
406
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
407
Statement of Net Assets Available for Benefits<BR>
408
(in 000&#146;s)</B></FONT> </P>
409
410
411
<HR SIZE=2 WIDTH=100%>
412
<BR>
413
414
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">
415
<TR VALIGN="BOTTOM">
416
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
417
<TH COLSPAN="6"><FONT SIZE="-1">April 30,</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
418
<TR VALIGN="BOTTOM">
419
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
420
<TH COLSPAN="3"><FONT SIZE="-1">2001</FONT></TH>
421
<TH COLSPAN="3"><FONT SIZE="-1">2000</FONT></TH></TR>
422
<TR VALIGN="BOTTOM">
423
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
424
<TR VALIGN="BOTTOM">
425
<TD WIDTH="64%" ALIGN="LEFT">Investments at fair value:</TD>
426
<TD WIDTH="1%" ALIGN="LEFT">&nbsp;</TD>
427
<TD WIDTH="3%" ALIGN="LEFT">&nbsp;</TD>
428
<TD WIDTH="1%" ALIGN="RIGHT">&nbsp;</TD><TD WIDTH="12%" ALIGN="RIGHT"></TD>
429
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD>
430
<TD WIDTH="1%" ALIGN="RIGHT">&nbsp;</TD><TD WIDTH="12%" ALIGN="RIGHT"></TD>
431
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD></TR>
432
<TR VALIGN="BOTTOM">
433
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Medtronic Common Stock Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
434
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 614,016</TD>
435
<TD ALIGN="LEFT">&nbsp;</TD>
436
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 741,949</TD>
437
<TD ALIGN="LEFT">&nbsp;</TD></TR>
438
<TR VALIGN="BOTTOM">
439
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard 500 Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
440
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">130,136</TD>
441
<TD ALIGN="LEFT">&nbsp;</TD>
442
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">152,479</TD>
443
<TD ALIGN="LEFT">&nbsp;</TD></TR>
444
<TR VALIGN="BOTTOM">
445
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard PRIMECAP Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
446
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">115,104</TD>
447
<TD ALIGN="LEFT">&nbsp;</TD>
448
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">127,626</TD>
449
<TD ALIGN="LEFT">&nbsp;</TD></TR>
450
<TR VALIGN="BOTTOM">
451
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard Wellington Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
452
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">97,555</TD>
453
<TD ALIGN="LEFT">&nbsp;</TD>
454
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">88,723</TD>
455
<TD ALIGN="LEFT">&nbsp;</TD></TR>
456
<TR VALIGN="BOTTOM">
457
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard Windsor II Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
458
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">53,331</TD>
459
<TD ALIGN="LEFT">&nbsp;</TD>
460
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">43,901</TD>
461
<TD ALIGN="LEFT">&nbsp;</TD></TR>
462
<TR VALIGN="BOTTOM">
463
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard Explorer Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
464
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">34,712</TD>
465
<TD ALIGN="LEFT">&nbsp;</TD>
466
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">33,775</TD>
467
<TD ALIGN="LEFT">&nbsp;</TD></TR>
468
<TR VALIGN="BOTTOM">
469
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard International Growth Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
470
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">28,652</TD>
471
<TD ALIGN="LEFT">&nbsp;</TD>
472
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">31,680</TD>
473
<TD ALIGN="LEFT">&nbsp;</TD></TR>
474
<TR VALIGN="BOTTOM">
475
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard U.S. Growth Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
476
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">23,401</TD>
477
<TD ALIGN="LEFT">&nbsp;</TD>
478
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">27,047</TD>
479
<TD ALIGN="LEFT">&nbsp;</TD></TR>
480
<TR VALIGN="BOTTOM">
481
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard Total Bond Market Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
482
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">17,325</TD>
483
<TD ALIGN="LEFT">&nbsp;</TD>
484
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">9,117</TD>
485
<TD ALIGN="LEFT">&nbsp;</TD></TR>
486
<TR VALIGN="BOTTOM">
487
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Vanguard Extended Market Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
488
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">9,861</TD>
489
<TD ALIGN="LEFT">&nbsp;</TD>
490
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">10,053</TD>
491
<TD ALIGN="LEFT">&nbsp;</TD></TR>
492
<TR VALIGN="BOTTOM">
493
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;Participant loans</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
494
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">14,270</TD>
495
<TD ALIGN="LEFT">&nbsp;</TD>
496
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">14,993</TD>
497
<TD ALIGN="LEFT">&nbsp;</TD></TR>
498
<TR>
499
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
500
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
501
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
502
<TR VALIGN="BOTTOM">
503
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
504
<TR VALIGN="BOTTOM">
505
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
506
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,138,363</TD>
507
<TD ALIGN="LEFT">&nbsp;</TD>
508
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,281,343</TD>
509
<TD ALIGN="LEFT">&nbsp;</TD></TR>
510
<TR VALIGN="BOTTOM">
511
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
512
<TR VALIGN="BOTTOM">
513
<TD ALIGN="LEFT">Medtronic Interest Income Fund, at contract value</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
514
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">149,718</TD>
515
<TD ALIGN="LEFT">&nbsp;</TD>
516
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">132,140</TD>
517
<TD ALIGN="LEFT">&nbsp;</TD></TR>
518
<TR>
519
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
520
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
521
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
522
<TR VALIGN="BOTTOM">
523
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
524
<TR VALIGN="BOTTOM">
525
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
526
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,288,081</TD>
527
<TD ALIGN="LEFT">&nbsp;</TD>
528
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,413,483</TD>
529
<TD ALIGN="LEFT">&nbsp;</TD></TR>
530
<TR VALIGN="BOTTOM">
531
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
532
<TR VALIGN="BOTTOM">
533
<TD ALIGN="LEFT">Contributions receivable from employees</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
534
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">3,361</TD>
535
<TD ALIGN="LEFT">&nbsp;</TD>
536
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">4,532</TD>
537
<TD ALIGN="LEFT">&nbsp;</TD></TR>
538
<TR>
539
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
540
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
541
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
542
<TR VALIGN="BOTTOM">
543
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
544
<TR VALIGN="BOTTOM">
545
<TD ALIGN="LEFT">Net assets available for benefits</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
546
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,291,442</TD>
547
<TD ALIGN="LEFT">&nbsp;</TD>
548
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,418,015</TD>
549
<TD ALIGN="LEFT">&nbsp;</TD></TR>
550
<TR>
551
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
552
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD>
553
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD></TR>
554
</TABLE>
555
<BR><BR><BR><BR>
556
557
<!-- MARKER FORMAT-SHEET="Para Center" -->
558
<P ALIGN="CENTER">The accompanying notes are an integral part of these financial
559
statements.</P>
560
561
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
562
<P ALIGN="CENTER">2</P>
563
564
565
566
567
568
569
<PAGE>
570
571
572
573
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
574
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
575
Statement of Changes in Net Assets Available for Benefits<BR>
576
(in 000&#146;s)</B></FONT> </P>
577
578
579
<HR SIZE=2 WIDTH=100%>
580
<BR>
581
582
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"WIDTH="600">
583
<TR VALIGN="BOTTOM">
584
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
585
<TH COLSPAN="6"><FONT SIZE="-1">Year Ended April 30,</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
586
<TR VALIGN="BOTTOM">
587
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
588
<TH COLSPAN="3"><FONT SIZE="-1">2001</FONT></TH>
589
<TH COLSPAN="3"><FONT SIZE="-1">2000</FONT></TH></TR>
590
<TR VALIGN="BOTTOM">
591
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
592
<TR VALIGN="BOTTOM">
593
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
594
<TR VALIGN="BOTTOM">
595
<TD WIDTH="69%" ALIGN="LEFT">Contributions from employees</TD>
596
<TD WIDTH="1%" ALIGN="LEFT">&nbsp;</TD>
597
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD>
598
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="10%" ALIGN="RIGHT"> 77,975</TD>
599
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD>
600
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="10%" ALIGN="RIGHT"> 68,354</TD>
601
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD></TR>
602
<TR VALIGN="BOTTOM">
603
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
604
<TR VALIGN="BOTTOM">
605
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
606
<TR VALIGN="BOTTOM">
607
<TD ALIGN="LEFT">Investment activity:</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
608
<TR VALIGN="BOTTOM">
609
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;Interest and dividend income</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
610
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">50,569</TD>
611
<TD ALIGN="LEFT">&nbsp;</TD>
612
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">41,953</TD>
613
<TD ALIGN="LEFT">&nbsp;</TD></TR>
614
<TR VALIGN="BOTTOM">
615
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;Net (depreciation) appreciation in fair value of investments</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
616
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(169,109</TD>
617
<TD ALIGN="LEFT">)</TD>
618
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">257,736</TD>
619
<TD ALIGN="LEFT">&nbsp;</TD></TR>
620
<TR>
621
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
622
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
623
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
624
<TR VALIGN="BOTTOM">
625
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
626
<TR VALIGN="BOTTOM">
627
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;Total investment (loss) income</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
628
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(118,540</TD>
629
<TD ALIGN="LEFT">)</TD>
630
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">299,689</TD>
631
<TD ALIGN="LEFT">&nbsp;</TD></TR>
632
<TR VALIGN="BOTTOM">
633
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
634
<TR VALIGN="BOTTOM">
635
<TD ALIGN="LEFT">Assets transferred from other plans (Note 9)</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
636
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">9,630</TD>
637
<TD ALIGN="LEFT">&nbsp;</TD>
638
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">57,977</TD>
639
<TD ALIGN="LEFT">&nbsp;</TD></TR>
640
<TR VALIGN="BOTTOM">
641
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
642
<TR VALIGN="BOTTOM">
643
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
644
<TR VALIGN="BOTTOM">
645
<TD ALIGN="LEFT">Benefit payments</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
646
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(95,598</TD>
647
<TD ALIGN="LEFT">)</TD>
648
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(69,444</TD>
649
<TD ALIGN="LEFT">)</TD></TR>
650
<TR VALIGN="BOTTOM">
651
<TD ALIGN="LEFT">Administrative fees</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
652
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(40</TD>
653
<TD ALIGN="LEFT">)</TD>
654
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(49</TD>
655
<TD ALIGN="LEFT">)</TD></TR>
656
<TR>
657
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
658
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
659
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
660
<TR VALIGN="BOTTOM">
661
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
662
<TR VALIGN="BOTTOM">
663
<TD ALIGN="LEFT">(Decrease) increase in net assets</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
664
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(126,573</TD>
665
<TD ALIGN="LEFT">)</TD>
666
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">356,527</TD>
667
<TD ALIGN="LEFT">&nbsp;</TD></TR>
668
<TR VALIGN="BOTTOM">
669
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
670
<TR VALIGN="BOTTOM">
671
<TD ALIGN="LEFT">Net assets available for benefits:</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
672
<TR VALIGN="BOTTOM">
673
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;Beginning of year</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
674
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,418,015</TD>
675
<TD ALIGN="LEFT">&nbsp;</TD>
676
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">1,061,488</TD>
677
<TD ALIGN="LEFT">&nbsp;</TD></TR>
678
<TR>
679
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
680
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
681
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
682
<TR VALIGN="BOTTOM">
683
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
684
<TR VALIGN="BOTTOM">
685
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;End of year</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
686
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,291,442</TD>
687
<TD ALIGN="LEFT">&nbsp;</TD>
688
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,418,015</TD>
689
<TD ALIGN="LEFT">&nbsp;</TD></TR>
690
<TR>
691
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
692
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD>
693
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD></TR>
694
</TABLE>
695
<BR><BR><BR><BR>
696
697
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
698
<P ALIGN="CENTER">The accompanying notes are an integral part of these financial
699
statements.</P>
700
701
702
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
703
<P ALIGN="CENTER">3</P>
704
705
706
707
708
709
710
<PAGE>
711
712
713
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
714
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
715
Notes to Financial Statements</B></FONT> </P>
716
717
<HR SIZE=2 WIDTH=100%>
718
<BR>
719
720
<!-- MARKER FORMAT-SHEET="Para Hang" -->
721
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
722
<TR VALIGN=TOP>
723
<TD WIDTH=5%><FONT SIZE="3"><B>1.</B></FONT> </TD>
724
<TD WIDTH=95%><FONT SIZE="3"><B>Description
725
of the Plan</B></FONT></TD>
726
</TR>
727
</TABLE>
728
<BR>
729
730
<!-- MARKER FORMAT-SHEET="Para Hang" -->
731
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
732
<TR VALIGN=TOP>
733
<TD WIDTH=5%>&nbsp;</TD>
734
<TD WIDTH=95%><FONT SIZE=3>
735
The
736
following description of the Medtronic, Inc. and Participating Employers Supplemental
737
Retirement Plan (the &#147;Plan&#148;) provides only general information. Participants
738
should refer to the Plan document for a complete description of the Plan&#146;s
739
provisions.</FONT></TD>
740
</TR>
741
</TABLE>
742
<BR>
743
744
<!-- MARKER FORMAT-SHEET="Para Hang" -->
745
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
746
<TR VALIGN=TOP>
747
<TD WIDTH=5%>&nbsp;</TD>
748
<TD WIDTH=95%>
749
<FONT SIZE=3><B>General</B><BR>The
750
Plan is a defined contribution plan created by Medtronic, Inc. (the
751
&#147;Company&#148;). The Company established the Plan to help employees
752
increase retirement savings and provide financial security upon retirement. The
753
Plan is available to all eligible regular full-time and part-time employees
754
immediately upon hire. Employee contributions are subject to certain IRS limits
755
on allowable compensation and maximum contribution amounts. The Plan qualifies
756
under Section 401(a) of the Internal Revenue Code of 1986, as amended, and is
757
subject to the provisions of the Employee Retirement Income Security Act of 1974
758
(ERISA), as amended.</FONT></TD>
759
</TR>
760
</TABLE>
761
<BR>
762
763
<!-- MARKER FORMAT-SHEET="Para Hang" -->
764
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
765
<TR VALIGN=TOP>
766
<TD WIDTH=5%>&nbsp;</TD>
767
<TD WIDTH=95%><FONT SIZE=3>
768
The
769
Board of Directors has approved the merger of the Plan into the Medtronic, Inc.
770
Employee Stock Ownership and Supplemental Retirement Plan. As of May 31, 2001,
771
all Plan assets and related benefit obligations had been transferred to the
772
Medtronic, Inc. Employee Stock Ownership and Supplemental Retirement Plan.</FONT></TD>
773
</TR>
774
</TABLE>
775
<BR>
776
777
<!-- MARKER FORMAT-SHEET="Para Hang" -->
778
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
779
<TR VALIGN=TOP>
780
<TD WIDTH=5%>&nbsp;</TD>
781
<TD WIDTH=95%>
782
<FONT SIZE=3><B>Administration</B><BR>The
783
Qualified Plan Committee of the Company oversees the administration of the Plan. The
784
committee appointed The Vanguard Fiduciary Trust Company as Trustee of the plan assets and
785
Recordkeeper of the Plan. The Vanguard Fiduciary Trust Company (hereinafter
786
referred to as the &#147;Trustee&#148;) has been appointed to provide
787
participant services, education and communication services. The Trustee
788
maintains a separate account in the name of each participant in the Plan to
789
record the assets allocated to the participant and the earnings, losses,
790
disbursement and expenses credited thereto.</FONT></TD>
791
</TR>
792
</TABLE>
793
<BR>
794
795
<!-- MARKER FORMAT-SHEET="Para Hang" -->
796
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
797
<TR VALIGN=TOP>
798
<TD WIDTH=5%>&nbsp;</TD>
799
<TD WIDTH=95%>
800
<FONT SIZE=3><B>Contributions</B><BR>Participating
801
employees may contribute to the Plan a minimum of 2% up to a maximum of 15%
802
(2000: maximum of 12%) of eligible earnings on a pre-tax basis. The Company
803
makes no matching contribution directly to the Plan, however the Company makes a
804
matching allocation of Medtronic common stock to the Employee Stock Ownership
805
Plan account. This matching allocation is at least 50%, up to a maximum of 150%
806
, of the employee contributions, limited to 6% of eligible compensation. The
807
Company match totaled approximately $33,063,000 and $32,046,000 for fiscal years
808
2001 and 2000, respectively.</FONT></TD>
809
</TR>
810
</TABLE>
811
<BR>
812
813
<!-- MARKER FORMAT-SHEET="Para Hang" -->
814
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
815
<TR VALIGN=TOP>
816
<TD WIDTH=5%>&nbsp;</TD>
817
<TD WIDTH=95%><FONT SIZE=3>
818
Contributions
819
are made to the Plan by participants through payroll deductions. The
820
contributions are allocated to eleven investment choices based upon participant
821
investment decisions. The participants may change the investment decisions at
822
any time by contacting the Trustee. However, any funds exchanged out of the
823
Medtronic Interest Income Fund must remain invested in another investment
824
alternative for a period of at least three months before being moved to the
825
Vanguard Total Bond Market Index Fund.</FONT></TD>
826
</TR>
827
</TABLE>
828
<BR>
829
830
<!-- MARKER FORMAT-SHEET="Para Hang" -->
831
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
832
<TR VALIGN=TOP>
833
<TD WIDTH=5%>&nbsp;</TD>
834
<TD WIDTH=95%>
835
<FONT SIZE=3><B>Vesting</B><BR>Participants
836
are 100% vested in their contributions at all times. Participants are 20% vested
837
in the Company contributions upon completing one year of service. Vesting in the
838
Company contributions accrues at the rate of 20% per year thereafter;
839
participants are fully vested on all Company&#146;s contributions after five
840
years. Participant forfeiture of nonvested amounts reduce the Company</FONT></TD>
841
</TR>
842
</TABLE>
843
<BR><BR>
844
845
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
846
<P ALIGN="CENTER">4</P>
847
848
849
850
851
852
853
<PAGE>
854
855
856
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
857
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
858
Notes to Financial Statements</B></FONT> </P>
859
860
<HR SIZE=2 WIDTH=100%>
861
<BR>
862
863
<!-- MARKER FORMAT-SHEET="Para Hang" -->
864
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
865
<TR VALIGN=TOP>
866
<TD WIDTH=5%>&nbsp;</TD>
867
<TD WIDTH=95%><FONT SIZE=3>
868
contribution. During fiscal years 2001 and 2000, $867,000 and $529,000,
869
respectively, were forfeited by terminating employees before these amounts
870
became vested.</FONT></TD>
871
</TR>
872
</TABLE>
873
<BR>
874
875
<!-- MARKER FORMAT-SHEET="Para Hang" -->
876
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
877
<TR VALIGN=TOP>
878
<TD WIDTH=5%>&nbsp;</TD>
879
<TD WIDTH=95%><FONT SIZE=3>
880
<B>Distributions</B><BR>An
881
active participant who has attained age 59 &frac12; may request a cash distribution for all or a
882
part of the value of the account.</FONT></TD>
883
</TR>
884
</TABLE>
885
<BR>
886
887
<!-- MARKER FORMAT-SHEET="Para Hang" -->
888
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
889
<TR VALIGN=TOP>
890
<TD WIDTH=5%>&nbsp;</TD>
891
<TD WIDTH=95%><FONT SIZE=3>
892
Upon
893
termination of employment, the participant must take a complete distribution if
894
the value of the participant&#146;s account is under $5,000. If the value of the
895
participant&#146;s account is greater than $5,000, the participant may elect to
896
defer distribution until a later date, take a cash withdrawal or request a
897
direct rollover. Participant funds invested in Medtronic stock may be taken
898
in-kind or as cash. Upon retirement from the Company, the participants also have
899
the option to take monthly installments from the Plan.</FONT></TD>
900
</TR>
901
</TABLE>
902
<BR>
903
904
<!-- MARKER FORMAT-SHEET="Para Hang" -->
905
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
906
<TR VALIGN=TOP>
907
<TD WIDTH=5%>&nbsp;</TD>
908
<TD WIDTH=95%><FONT SIZE=3>
909
Participants
910
may take hardship withdrawals from the Plan if they incur financial hardship.
911
The hardship withdrawal is only available to meet immediate and severe financial
912
needs that cannot be met through other available sources in the Plan including
913
the available loan provisions. The amount of the hardship withdrawal cannot
914
exceed the amount of the financial need and will be taxed upon distribution with
915
a 10% penalty tax imposed.</FONT></TD>
916
</TR>
917
</TABLE>
918
<BR>
919
920
<!-- MARKER FORMAT-SHEET="Para Hang" -->
921
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
922
<TR VALIGN=TOP>
923
<TD WIDTH=5%>&nbsp;</TD>
924
<TD WIDTH=95%><FONT SIZE=3>
925
Upon
926
the death of a participant, the account becomes fully vested and will be paid to
927
the designated beneficiary, or if no beneficiary has been designated, the
928
balance will be paid according to the terms and conditions of the Plan. The
929
beneficiary has the option to take the Medtronic stock in-kind or as cash.</FONT></TD>
930
</TR>
931
</TABLE>
932
<BR>
933
934
<!-- MARKER FORMAT-SHEET="Para Hang" -->
935
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
936
<TR VALIGN=TOP>
937
<TD WIDTH=5%>&nbsp;</TD>
938
<TD WIDTH=95%>
939
<FONT SIZE=3><B>Participant Loans</B><BR>Participants
940
can have only one loan outstanding at a time and can borrow up to 50% of their
941
vested balance not to exceed the maximum loan amount of $50,000. The minimum
942
loan amount is $1,000. Loans are repaid through payroll deduction in equal
943
amounts over a 1 to 5 year period. The interest rate is calculated as one
944
percentage point over the prime rate in effect at US Bank, N.A., on the first
945
workday of the month in which the loan is made and remains fixed for the
946
duration for the loan.</FONT></TD>
947
</TR>
948
</TABLE>
949
<BR>
950
951
<!-- MARKER FORMAT-SHEET="Para Hang" -->
952
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
953
<TR VALIGN=TOP>
954
<TD WIDTH=5%>&nbsp;</TD>
955
<TD WIDTH=95%>
956
<FONT SIZE=3><B>Termination of the Plan</B><BR>Termination
957
or retirement benefits are paid by the Trustee in accordance with the provisions
958
of the Plan and the instructions of Medtronic, Inc., acting as plan
959
administrator. In the event the Plan were terminated, participants become fully
960
vested in the Company contributions and the Company would cause all amounts in the
961
hands of the Trustee to be allocated and distributed to the participants based
962
upon their investment balance.</FONT></TD>
963
</TR>
964
</TABLE>
965
<BR>
966
967
<!-- MARKER FORMAT-SHEET="Para Hang" -->
968
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
969
<TR VALIGN=TOP>
970
<TD WIDTH=5%>&nbsp;</TD>
971
<TD WIDTH=95%>
972
<FONT SIZE=3><B>Plan Amendments</B><BR>During
973
the current year, the Plan was amended to a) eliminate the one-year wait upon
974
reemployment for purposes of crediting vesting; b) include all prior years of
975
service in calculating the vested percentage of rehired employees and c) permit
976
Participants to elect a percentage of elective deferral contributions for
977
a plan year that is applied against their total credited compensation without
978
regard to the Internal Revenue Code limitations, provided such percentage does
979
not exceed 15% of the Participant&#146;s covered compensation, as defined in the
980
Plan.</FONT></TD>
981
</TR>
982
</TABLE>
983
<BR>
984
985
<!-- MARKER FORMAT-SHEET="Para Hang" -->
986
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
987
<TR VALIGN=TOP>
988
<TD WIDTH=5%><FONT SIZE="3"><B>2.</B></FONT> </TD>
989
<TD WIDTH=95%><FONT SIZE="3"><B>Summary
990
of Accounting Principles</B></FONT></TD>
991
</TR>
992
</TABLE>
993
<BR>
994
995
<!-- MARKER FORMAT-SHEET="Para Hang" -->
996
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
997
<TR VALIGN=TOP>
998
<TD WIDTH=5%>&nbsp;</TD>
999
<TD WIDTH=95%>
1000
<FONT SIZE=3><B>Basis of Presentation</B><BR>The
1001
accompanying financial statements are prepared on the accrual basis of accounting.</FONT></TD>
1002
</TR>
1003
</TABLE>
1004
<BR>
1005
1006
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1007
<P ALIGN="CENTER">5</P>
1008
1009
1010
1011
1012
1013
1014
1015
<PAGE>
1016
1017
1018
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1019
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
1020
Notes to Financial Statements</B></FONT> </P>
1021
1022
<HR SIZE=2 WIDTH=100%>
1023
<BR>
1024
1025
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1026
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1027
<TR VALIGN=TOP>
1028
<TD WIDTH=5%>&nbsp;</TD>
1029
<TD WIDTH=95%>
1030
<FONT SIZE="3"><B>Valuation of Investments</B><BR>The
1031
Plan&#146;s investments are stated at fair value, except for its investment
1032
contracts, which are valued at contract value. Shares of registered investment
1033
companies are valued at quoted market prices which represent the net asset value
1034
of shares held by the Plan at year-end. The Company stock fund is valued at its
1035
year-end unit closing price (comprised of year-end market price plus uninvested
1036
cash position.) Participant loans are valued at estimated fair value, consisting
1037
of outstanding prinicipal and related unpaid interest.</FONT></TD>
1038
</TR>
1039
</TABLE>
1040
<BR>
1041
1042
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1043
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1044
<TR VALIGN=TOP>
1045
<TD WIDTH=5%>&nbsp;</TD>
1046
<TD WIDTH=95%>
1047
<FONT SIZE="3"><B>Use of Estimates</B><BR>The
1048
preparation of the financial statements in conformity with accounting principles
1049
generally accepted in the United States of America requires management to make
1050
estimates and assumptions that affect the amounts reported in the financial
1051
statements and accompanying notes. Actual results could differ from those
1052
estimates.</FONT></TD>
1053
</TR>
1054
</TABLE>
1055
<BR>
1056
1057
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1058
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1059
<TR VALIGN=TOP>
1060
<TD WIDTH=5%>&nbsp;</TD>
1061
<TD WIDTH=95%>
1062
<FONT SIZE="3"><B>Investment Transactions and Related Investment Income</B><BR>Purchases
1063
and sales of investments are recorded on a trade-date basis. Realized gains and
1064
losses on sales of investments are based on average cost at the time of the
1065
sale. Interest income is accrued when earned. Dividend income is recorded on the
1066
ex-dividend date. Capital gain distributions are included in dividend income.</FONT></TD>
1067
</TR>
1068
</TABLE>
1069
<BR>
1070
1071
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1072
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1073
<TR VALIGN=TOP>
1074
<TD WIDTH=5%>&nbsp;</TD>
1075
<TD WIDTH=95%>
1076
<FONT SIZE="3"><B>Administrative Expenses</B><BR>Administrative
1077
expenses are paid by the Plan for the administration of the Plan and maintenance
1078
of the accounts. Such expenses consist of recordkeeping fees, trustee fees,
1079
account maintenance fees, and annual loan fees. The Company pays for the fees
1080
associated with transactions in the Medtronic Common Stock Fund.</FONT></TD>
1081
</TR>
1082
</TABLE>
1083
<BR>
1084
1085
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1086
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1087
<TR VALIGN=TOP>
1088
<TD WIDTH=5%>&nbsp;</TD>
1089
<TD WIDTH=95%>
1090
<FONT SIZE="3"><B>Payment of Benefits</B><BR>Benefits
1091
are recorded when paid.</FONT></TD>
1092
</TR>
1093
</TABLE>
1094
<BR>
1095
1096
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1097
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1098
<TR VALIGN=TOP>
1099
<TD WIDTH=5%>&nbsp;</TD>
1100
<TD WIDTH=95%>
1101
<FONT SIZE="3"><B>Risks and Uncertainties</B><BR>The
1102
Plan provides for various participant investment options in funds, which can
1103
invest in any combination of stocks, bonds, fixed income securities, mutual
1104
fund, and other investment securities. Investment securities are exposed to
1105
various risks, such as interest rate, market and credit. Due to the level of
1106
risk associated with certain investment securities and the level of uncertainty
1107
related to changes in the value of investment securities, it is at least
1108
reasonably possible that changes in risks in the near term would materially
1109
affect participants&#146; account balances and the amounts reported in the
1110
Statements of Net Assets Available for Benefits and the Statements of Changes in
1111
Net Assets Available for Benefits.</FONT></TD>
1112
</TR>
1113
</TABLE>
1114
<BR>
1115
1116
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1117
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1118
<TR VALIGN=TOP>
1119
<TD WIDTH=5%>&nbsp;</TD>
1120
<TD WIDTH=95%>
1121
<FONT SIZE="3"><B>New Accounting Standards</B><BR>In
1122
June 1998, the Financial Accounting Standards Board issued Statement of Financial
1123
Accounting Standards No. 133, &#147;Accounting for Derivative Instruments and Hedging
1124
Activities&#148; (SFAS No. 133). SFAS No. 133 requires that an entity recognize all
1125
derivatives and measure those instruments at fair value.</FONT></TD>
1126
</TR>
1127
</TABLE>
1128
<BR>
1129
1130
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1131
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1132
<TR VALIGN=TOP>
1133
<TD WIDTH=5%>&nbsp;</TD>
1134
<TD WIDTH=95%><FONT SIZE=3>
1135
SFAS
1136
No. 133 is effective for fiscal years beginning after June 15, 2000. Pursuant to
1137
Statement of Financial Accounting Standards No. 137, &#147;Accounting for
1138
Derivative Instruments and Hedging Activities-Deferral of the Effective Date of
1139
FASB Statement No. 133- an Amendment of FASB Statement No. 133,&#148; the Plan
1140
is required to adopt SFAS No. 133 effective May 1, 2001. Management</FONT></TD>
1141
</TR>
1142
</TABLE>
1143
<BR>
1144
1145
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1146
<P ALIGN="CENTER">6</P>
1147
1148
1149
1150
1151
1152
1153
1154
<PAGE>
1155
1156
1157
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1158
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
1159
Notes to Financial Statements</B></FONT> </P>
1160
1161
<HR SIZE=2 WIDTH=100%>
1162
<BR>
1163
1164
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1165
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1166
<TR VALIGN=TOP>
1167
<TD WIDTH=5%>&nbsp;</TD>
1168
<TD WIDTH=95%><FONT SIZE=3>
1169
has not yet
1170
been able to determine the impact of SFAS No. 133 on the Plan financial
1171
statements as a result of the inconsistency in accounting literature between
1172
SFAS No. 133, requiring derivatives to be measured at fair
1173
value, and the AICPA Audit and Accounting Guide on &#147;Audits of Employee
1174
Benefit Plans&#148; and Statement of Position 94-4, &#147;Reporting of
1175
Investment Contracts Held by Health and Welfare Benefit Plans and
1176
Defined-Contribution Pension Plans&#148;, requiring benefit responsive
1177
investment contracts (including synthetic GICs) to be measured at contract
1178
value. Until this discrepancy is resolved, management is unable to determine the
1179
impact that SFAS 133 will have on the Plan financial statements. The carrying
1180
value of those instruments is approximately $149,700,000 at April 30, 2001.</FONT></TD>
1181
</TR>
1182
</TABLE>
1183
<BR>
1184
1185
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1186
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1187
<TR VALIGN=TOP>
1188
<TD WIDTH=5%><FONT SIZE="3"><B>3.</B></FONT> </TD>
1189
<TD WIDTH=95%><FONT SIZE="3"><B>Description
1190
of Investment Funds</B></FONT></TD>
1191
</TR>
1192
</TABLE>
1193
<BR>
1194
1195
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1196
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1197
<TR VALIGN=TOP>
1198
<TD WIDTH=5%>&nbsp;</TD>
1199
<TD WIDTH=95%><FONT SIZE=3>
1200
The
1201
objectives of the eleven investment funds to which participants were able to
1202
allocate their contributions during the plan years ended April 30, 2001 and 2000
1203
are described as follows:</FONT></TD>
1204
</TR>
1205
</TABLE>
1206
<BR>
1207
1208
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1209
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1210
<TR VALIGN=TOP>
1211
<TD WIDTH=5%>&nbsp;</TD>
1212
<TD WIDTH=95%>
1213
<FONT SIZE="3"><I>Medtronic
1214
Common Stock Fund</I>: Invests in Medtronic, Inc. common stock to provide the possibility of
1215
long-term growth through increases in the value of the stock and the reinvestment of its
1216
dividends. Among the factors affecting the stock&#146;s potential growth are the Company&#146;s
1217
ability to expand its commitment to new technology and products and to enter new markets.</FONT></TD>
1218
</TR>
1219
</TABLE>
1220
<BR>
1221
1222
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1223
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1224
<TR VALIGN=TOP>
1225
<TD WIDTH=5%>&nbsp;</TD>
1226
<TD WIDTH=95%><FONT SIZE=3>
1227
<I>Vanguard
1228
500 Index Fund</I>: Seeks to provide long-term growth of capital and income from
1229
dividends by holding all of the 500 stocks that make up the unmanaged Standard
1230
&amp; Poor&#146;s 500 Composite Stock Price Index, a widely recognized benchmark
1231
of U.S. stock market performance.</FONT></TD>
1232
</TR>
1233
</TABLE>
1234
<BR>
1235
1236
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1237
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1238
<TR VALIGN=TOP>
1239
<TD WIDTH=5%>&nbsp;</TD>
1240
<TD WIDTH=95%>
1241
<FONT SIZE="3"><I>Vanguard
1242
PRIMECAP Fund</I>: Seeks long-term growth of capital by investing in stocks of companies with
1243
above-average prospects for continued earnings growth, strong industry positions, and
1244
skilled management teams.</FONT></TD>
1245
</TR>
1246
</TABLE>
1247
<BR>
1248
1249
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1250
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1251
<TR VALIGN=TOP>
1252
<TD WIDTH=5%>&nbsp;</TD>
1253
<TD WIDTH=95%><FONT SIZE=3>
1254
<I>Vanguard
1255
Wellington Fund</I>: Seeks to provide income and long-term growth of capital
1256
without undue risk to capital by investing about 65% of its assets in stocks and
1257
the remaining 35% in bonds.</FONT></TD>
1258
</TR>
1259
</TABLE>
1260
<BR>
1261
1262
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1263
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1264
<TR VALIGN=TOP>
1265
<TD WIDTH=5%>&nbsp;</TD>
1266
<TD WIDTH=95%><FONT SIZE=3>
1267
<I>Vanguard
1268
Windsor II Fund</I>: Seeks to provide income and long-term growth of capital and
1269
income from dividends by investing in a diversified group of out-of-favor stocks
1270
of large-capitalization companies. The stocks generally sell at prices below the
1271
overall market average compared to their dividend income and future return
1272
potential.</FONT></TD>
1273
</TR>
1274
</TABLE>
1275
<BR>
1276
1277
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1278
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1279
<TR VALIGN=TOP>
1280
<TD WIDTH=5%>&nbsp;</TD>
1281
<TD WIDTH=95%>
1282
<FONT SIZE="3"><I>Vanguard
1283
Explorer Fund</I>: Seeks to provide long-term growth of capital by investing in a diversified
1284
group of small-company stocks with prospects for above-average growth.</FONT></TD>
1285
</TR>
1286
</TABLE>
1287
<BR>
1288
1289
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1290
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1291
<TR VALIGN=TOP>
1292
<TD WIDTH=5%>&nbsp;</TD>
1293
<TD WIDTH=95%><FONT SIZE=3>
1294
<I>Vanguard
1295
International Growth Fund</I>: Seeks to provide long-term growth of capital by
1296
investing in stocks of high-quality, seasoned companies based outside the United
1297
States of America. Stocks are selected from more than 15 countries.</FONT></TD>
1298
</TR>
1299
</TABLE>
1300
<BR>
1301
1302
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1303
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1304
<TR VALIGN=TOP>
1305
<TD WIDTH=5%>&nbsp;</TD>
1306
<TD WIDTH=95%>
1307
<FONT SIZE="3"><I>Vanguard
1308
U.S. Growth Fund</I>: Seeks to provide long-term growth of capital by investing in large,
1309
high-quality, seasoned U.S. companies with records of exceptional growth and
1310
above-average prospects for future growth.</FONT></TD>
1311
</TR>
1312
</TABLE>
1313
<BR><BR>
1314
1315
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1316
<P ALIGN="CENTER">7</P>
1317
1318
1319
1320
1321
1322
1323
1324
<PAGE>
1325
1326
1327
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1328
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
1329
Notes to Financial Statements</B></FONT> </P>
1330
1331
<HR SIZE=2 WIDTH=100%>
1332
<BR>
1333
1334
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1335
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1336
<TR VALIGN=TOP>
1337
<TD WIDTH=5%>&nbsp;</TD>
1338
<TD WIDTH=95%><FONT SIZE=3>
1339
<I>Vanguard
1340
Total Bond Market Index Fund</I>: Seeks to provide a high level of interest
1341
income by attempting to match the performance of the unmanaged Lehman Brothers
1342
Aggregate Bond Index, which is a widely recognized measure of the entire taxable
1343
U.S. bond market.</FONT></TD>
1344
</TR>
1345
</TABLE>
1346
<BR>
1347
1348
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1349
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1350
<TR VALIGN=TOP>
1351
<TD WIDTH=5%>&nbsp;</TD>
1352
<TD WIDTH=95%><FONT SIZE=3>
1353
<I>Vanguard
1354
Extended Market Index Fund</I>: Seeks to provide long-term growth of capital by
1355
attempting to match the performance of the Wilshire 4500 Equity Index, an
1356
unmanaged index made up mostly of mid- and small- capitalization companies.</FONT></TD>
1357
</TR>
1358
</TABLE>
1359
<BR>
1360
1361
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1362
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1363
<TR VALIGN=TOP>
1364
<TD WIDTH=5%>&nbsp;</TD>
1365
<TD WIDTH=95%><FONT SIZE=3>
1366
<I>Medtronic
1367
Interest Income Fund</I>: Seeks to preserve the value of capital and provide an
1368
attractive level of interest by investing primarily in investment contracts
1369
issued by insurance companies and banks. It is designed to maintain a constant
1370
$1.00 share value.</FONT></TD>
1371
</TR>
1372
</TABLE>
1373
<BR>
1374
1375
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1376
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1377
<TR VALIGN=TOP>
1378
<TD WIDTH=5%><FONT SIZE="3"><B>4.</B></FONT> </TD>
1379
<TD WIDTH=95%><FONT SIZE="3"><B>Investments</B></FONT></TD>
1380
</TR>
1381
</TABLE>
1382
<BR>
1383
1384
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1385
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1386
<TR VALIGN=TOP>
1387
<TD WIDTH=5%>&nbsp;</TD>
1388
<TD WIDTH=95%><FONT SIZE=3>
1389
The
1390
net (depreciation) appreciation in the fair value of investments during 2001 and
1391
2000, including investments purchased and sold, as well as those held during the
1392
year, was as follows (in 000&#146;s):</FONT></TD>
1393
</TR>
1394
</TABLE>
1395
<BR>
1396
1397
<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" BORDER="0" WIDTH="600">
1398
<TR VALIGN="BOTTOM">
1399
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1400
<TH COLSPAN="6"><FONT SIZE="-1">April 30</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
1401
<TR VALIGN="BOTTOM">
1402
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1403
<TH COLSPAN="3"><FONT SIZE="-1">2001</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH>
1404
<TH COLSPAN="3"><FONT SIZE="-1">2000</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
1405
<TR VALIGN="BOTTOM">
1406
<TD WIDTH="60%" ALIGN="LEFT">Medtronic Common Stock Fund</TD>
1407
<TD WIDTH="1%" ALIGN="LEFT">&nbsp;</TD>
1408
<TD WIDTH="3%" ALIGN="LEFT">&nbsp;</TD>
1409
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="10%" ALIGN="RIGHT"> (93,477</TD>
1410
<TD WIDTH="4%" ALIGN="LEFT">)</TD>
1411
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="10%" ALIGN="RIGHT"> 233,265</TD>
1412
<TD WIDTH="4%" ALIGN="LEFT">&nbsp;</TD></TR>
1413
<TR VALIGN="BOTTOM">
1414
<TD ALIGN="LEFT">Vanguard 500 Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1415
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(20,774</TD>
1416
<TD ALIGN="LEFT">)</TD>
1417
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">11,655</TD>
1418
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1419
<TR VALIGN="BOTTOM">
1420
<TD ALIGN="LEFT">Vanguard PRIMECAP Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1421
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(27,058</TD>
1422
<TD ALIGN="LEFT">)</TD>
1423
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">29,684</TD>
1424
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1425
<TR VALIGN="BOTTOM">
1426
<TD ALIGN="LEFT">Vanguard Wellington Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1427
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">4,472</TD>
1428
<TD ALIGN="LEFT">&nbsp;</TD>
1429
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(12,344</TD>
1430
<TD ALIGN="LEFT">)</TD></TR>
1431
<TR VALIGN="BOTTOM">
1432
<TD ALIGN="LEFT">Vanguard Windsor II Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1433
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">4,898</TD>
1434
<TD ALIGN="LEFT">&nbsp;</TD>
1435
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(14,584</TD>
1436
<TD ALIGN="LEFT">)</TD></TR>
1437
<TR VALIGN="BOTTOM">
1438
<TD ALIGN="LEFT">Vanguard Explorer Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1439
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(7,073</TD>
1440
<TD ALIGN="LEFT">)</TD>
1441
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">4,859</TD>
1442
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1443
<TR VALIGN="BOTTOM">
1444
<TD ALIGN="LEFT">Vanguard International Growth Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1445
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(7,543</TD>
1446
<TD ALIGN="LEFT">)</TD>
1447
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">3,390</TD>
1448
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1449
<TR VALIGN="BOTTOM">
1450
<TD ALIGN="LEFT">Vanguard U.S. Growth Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1451
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(19,317</TD>
1452
<TD ALIGN="LEFT">)</TD>
1453
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">2,456</TD>
1454
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1455
<TR VALIGN="BOTTOM">
1456
<TD ALIGN="LEFT">Vanguard Total Bond Market Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1457
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">557</TD>
1458
<TD ALIGN="LEFT">&nbsp;</TD>
1459
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(425</TD>
1460
<TD ALIGN="LEFT">)</TD></TR>
1461
<TR VALIGN="BOTTOM">
1462
<TD ALIGN="LEFT">Vanguard Extended Market Index Fund</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1463
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(3,794</TD>
1464
<TD ALIGN="LEFT">)</TD>
1465
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(220</TD>
1466
<TD ALIGN="LEFT">)</TD></TR>
1467
<TR>
1468
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1469
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
1470
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
1471
<TR VALIGN="BOTTOM">
1472
<TD ALIGN="LEFT">&nbsp;Net (depreciation) appreciation in</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
1473
<TR VALIGN="BOTTOM">
1474
<TD ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;fair value of investments</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1475
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> (169,109</TD>
1476
<TD ALIGN="LEFT">)</TD>
1477
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 257,736</TD>
1478
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1479
<TR>
1480
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1481
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD>
1482
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD></TR>
1483
</TABLE>
1484
<BR>
1485
1486
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1487
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1488
<TR VALIGN=TOP>
1489
<TD WIDTH=5%><FONT SIZE="3"><B>5.</B></FONT> </TD>
1490
<TD WIDTH=95%><FONT SIZE="3"><B>Medtronic
1491
Interest Income Fund</B></FONT></TD>
1492
</TR>
1493
</TABLE>
1494
<BR>
1495
1496
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1497
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1498
<TR VALIGN=TOP>
1499
<TD WIDTH=5%>&nbsp;</TD>
1500
<TD WIDTH=95%><FONT SIZE=3>
1501
The
1502
investments in the Medtronic Interest Income Fund consist of investment
1503
contracts issued by financial institutions and of contracts backed by
1504
investment-grade, fixed-income securities and bond mutual funds. These
1505
investment contracts are valued at their contract values, which approximate fair
1506
value because these investments have fully benefit-responsive features. There
1507
are no reserves against contract values for credit risk of contract issuers or
1508
otherwise.</FONT></TD>
1509
</TR>
1510
</TABLE>
1511
<BR>
1512
1513
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1514
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1515
<TR VALIGN=TOP>
1516
<TD WIDTH=5%>&nbsp;</TD>
1517
<TD WIDTH=95%><FONT SIZE=3>
1518
The
1519
average yield of the Medtronic Interest Income Fund was 6.38% and 6.54% for 2001
1520
and 2000, respectively. The crediting interest rate of the Medtronic Interest
1521
Income Fund was 6.45% and 6.23% for 2001 and 2000, respectively. The crediting
1522
interest rate is based on a formula agreed upon with the issuer, which cannot be
1523
less than zero. Such interest rates are reviewed on a quarterly basis for
1524
resetting.</FONT></TD>
1525
</TR>
1526
</TABLE>
1527
<BR>
1528
1529
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1530
<P ALIGN="CENTER">8</P>
1531
1532
1533
1534
1535
1536
1537
1538
<PAGE>
1539
1540
1541
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1542
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
1543
Notes to Financial Statements</B></FONT> </P>
1544
1545
<HR SIZE=2 WIDTH=100%>
1546
<BR>
1547
1548
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1549
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1550
<TR VALIGN=TOP>
1551
<TD WIDTH=5%><FONT SIZE="3"><B>6.</B></FONT> </TD>
1552
<TD WIDTH=95%><FONT SIZE="3"><B>Related
1553
Party Transactions</B></FONT></TD>
1554
</TR>
1555
</TABLE>
1556
<BR>
1557
1558
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1559
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1560
<TR VALIGN=TOP>
1561
<TD WIDTH=5%>&nbsp;</TD>
1562
<TD WIDTH=95%><FONT SIZE=3>
1563
The
1564
Plan invests in shares of mutual funds managed by an affiliate of Vanguard
1565
Trust. Vanguard Trust acts as trustee for only those investments of the Plan.
1566
Transactions in such investments qualify as party-in-interest transactions,
1567
which are exempt from the prohibited transaction rules.</FONT></TD>
1568
</TR>
1569
</TABLE>
1570
<BR>
1571
1572
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1573
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1574
<TR VALIGN=TOP>
1575
<TD WIDTH=5%>&nbsp;</TD>
1576
<TD WIDTH=95%><FONT SIZE=3>
1577
At
1578
April 30, 2001, the Plan held 13,767,179 shares of Medtronic, Inc. common stock
1579
valued at approximately $614,016,000. At April 30, 2000 the Plan held 14,285,417
1580
shares of Medtronic, Inc. common stock valued at approximately $741,949,000.</FONT></TD>
1581
</TR>
1582
</TABLE>
1583
<BR>
1584
1585
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1586
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1587
<TR VALIGN=TOP>
1588
<TD WIDTH=5%>&nbsp;</TD>
1589
<TD WIDTH=95%><FONT SIZE=3>
1590
Total
1591
purchases and sales, including purchases and sales of Medtronic stock, for the
1592
years ended April 30, 2001 and April 30, 2000 were $531,526,000 and $485,121,000
1593
and $507,369,000 and $404,879,000, respectively.</FONT></TD>
1594
</TR>
1595
</TABLE>
1596
<BR>
1597
1598
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1599
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1600
<TR VALIGN=TOP>
1601
<TD WIDTH=5%><FONT SIZE="3"><B>7.</B></FONT> </TD>
1602
<TD WIDTH=95%><FONT SIZE="3"><B>Reconciliation
1603
of Financial Statements to Form 5500</B></FONT></TD>
1604
</TR>
1605
</TABLE>
1606
<BR>
1607
1608
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1609
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1610
<TR VALIGN=TOP>
1611
<TD WIDTH=5%>&nbsp;</TD>
1612
<TD WIDTH=95%><FONT SIZE=3>
1613
The
1614
following is a reconciliation of net assets available for benefits per the financial
1615
statements to Form 5500 (in 000&#146;s):</FONT></TD>
1616
</TR>
1617
</TABLE>
1618
<BR>
1619
1620
<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" BORDER="0" WIDTH="600">
1621
<TR VALIGN="BOTTOM">
1622
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1623
<TH COLSPAN="6"><FONT SIZE="-1">April 30,</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
1624
<TR VALIGN="BOTTOM">
1625
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1626
<TH COLSPAN="3"><FONT SIZE="-1">2001</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH>
1627
<TH COLSPAN="3"><FONT SIZE="-1">2000</FONT><HR WIDTH=95% SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
1628
<TR VALIGN="BOTTOM">
1629
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
1630
<TR VALIGN="BOTTOM">
1631
<TD WIDTH="67%" ALIGN="LEFT">Net assets available for benefits per financial statements</TD>
1632
<TD WIDTH="1%" ALIGN="LEFT">&nbsp;</TD>
1633
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD>
1634
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="11%" ALIGN="RIGHT"> 1,291,442</TD>
1635
<TD WIDTH="4%" ALIGN="LEFT">&nbsp;</TD>
1636
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="11%" ALIGN="RIGHT"> 1,418,015</TD>
1637
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD></TR>
1638
<TR VALIGN="BOTTOM">
1639
<TD ALIGN="LEFT">Amounts allocated to withdrawing participants</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1640
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(4,945</TD>
1641
<TD ALIGN="LEFT">)</TD>
1642
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(6,579</TD>
1643
<TD ALIGN="LEFT">)</TD></TR>
1644
<TR>
1645
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1646
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD>
1647
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="1"></TD></TR>
1648
<TR VALIGN="BOTTOM">
1649
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
1650
<TR VALIGN="BOTTOM">
1651
<TD ALIGN="LEFT">Net assets available for benefits per Form 5500</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1652
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,286,497</TD>
1653
<TD ALIGN="LEFT">&nbsp;</TD>
1654
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 1,411,436</TD>
1655
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1656
<TR>
1657
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1658
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD>
1659
<TD COLSPAN="3"><HR WIDTH=95% NOSHADE COLOR="Black" SIZE="2"></TD></TR>
1660
</TABLE>
1661
<BR>
1662
1663
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1664
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1665
<TR VALIGN=TOP>
1666
<TD WIDTH=5%>&nbsp;</TD>
1667
<TD WIDTH=95%><FONT SIZE=3>
1668
The
1669
following is a reconciliation of benefits paid to participants per the financial
1670
statements to Form 5500 (in 000&#146;s):</FONT></TD>
1671
</TR>
1672
</TABLE>
1673
<BR>
1674
1675
<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" BORDER="0" WIDTH="600">
1676
<TR VALIGN="BOTTOM">
1677
<TH COLSPAN="3"><FONT SIZE="-1"></FONT></TH>
1678
<TH COLSPAN="3"><FONT SIZE="-1">Year Ended<BR>April 30,<BR>2001</FONT><HR SIZE=1 COLOR=BLACK NOSHADE></TH></TR>
1679
<TR VALIGN="BOTTOM">
1680
<TD WIDTH="80%" ALIGN="LEFT">Benefits paid to participants per financial statements</TD>
1681
<TD WIDTH="1%" ALIGN="LEFT">&nbsp;</TD>
1682
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD>
1683
<TD WIDTH="1%" ALIGN="RIGHT">$</TD><TD WIDTH="12%" ALIGN="RIGHT"> 95,598</TD>
1684
<TD WIDTH="2%" ALIGN="LEFT">&nbsp;</TD></TR>
1685
<TR VALIGN="BOTTOM">
1686
<TD ALIGN="LEFT">Add: Amounts allocated to withdrawing participants at April 30, 2001</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1687
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">4,945</TD>
1688
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1689
<TR VALIGN="BOTTOM">
1690
<TD ALIGN="LEFT">Less: Amounts allocated to withdrawing participants at April 30, 2000</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1691
<TD ALIGN="RIGHT">&nbsp;</TD><TD ALIGN="RIGHT">(6,579</TD>
1692
<TD ALIGN="LEFT">)</TD></TR>
1693
<TR>
1694
<TH COLSPAN="3"><FONT SIZE="1"></FONT></TH>
1695
<TD COLSPAN="3"><HR NOSHADE COLOR="Black" SIZE="1"></TD></TR>
1696
<TR VALIGN="BOTTOM">
1697
<TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD></TR>
1698
<TR VALIGN="BOTTOM">
1699
<TD ALIGN="LEFT">Benefits paid to participants per Form 5500</TD><TD ALIGN="LEFT">&nbsp;</TD><TD ALIGN="LEFT">&nbsp;</TD>
1700
<TD ALIGN="RIGHT">$</TD><TD ALIGN="RIGHT"> 93,964</TD>
1701
<TD ALIGN="LEFT">&nbsp;</TD></TR>
1702
<TR>
1703
<TH COLSPAN="3"><FONT SIZE="1"></FONT></TH>
1704
<TD COLSPAN="3"><HR NOSHADE COLOR="Black" SIZE="2"></TD></TR>
1705
</TABLE>
1706
<BR>
1707
1708
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1709
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1710
<TR VALIGN=TOP>
1711
<TD WIDTH=5%>&nbsp;</TD>
1712
<TD WIDTH=95%><FONT SIZE=3>
1713
Amounts
1714
allocated to withdrawing participants are recorded on Form 5500 for benefit
1715
claims that have been processed and approved for payment prior to April 30, but
1716
have not yet been paid as of that date.</FONT></TD>
1717
</TR>
1718
</TABLE>
1719
<BR>
1720
1721
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1722
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1723
<TR VALIGN=TOP>
1724
<TD WIDTH=5%><FONT SIZE="3"><B>8.</B></FONT> </TD>
1725
<TD WIDTH=95%><FONT SIZE="3"><B>Tax
1726
Status</B></FONT></TD>
1727
</TR>
1728
</TABLE>
1729
<BR>
1730
1731
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1732
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1733
<TR VALIGN=TOP>
1734
<TD WIDTH=5%>&nbsp;</TD>
1735
<TD WIDTH=95%><FONT SIZE=3>
1736
The
1737
Plan received a favorable determination letter from the Internal Revenue Service
1738
on March 28, 1996. Although the Plan has been amended since receiving the
1739
determination letter, the Plan</FONT></TD>
1740
</TR>
1741
</TABLE>
1742
<BR>
1743
1744
1745
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1746
<P ALIGN="CENTER">9</P>
1747
1748
1749
1750
1751
1752
1753
<PAGE>
1754
1755
1756
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1757
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR>Retirement Plan<BR>
1758
Notes to Financial Statements</B></FONT> </P>
1759
1760
<HR SIZE=2 WIDTH=100%>
1761
<BR>
1762
1763
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1764
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1765
<TR VALIGN=TOP>
1766
<TD WIDTH=5%>&nbsp;</TD>
1767
<TD WIDTH=95%><FONT SIZE=3>
1768
administrator and the Plan&#146;s tax counsel
1769
continue to believe the Plan is designed and is being operated in compliance
1770
with the applicable requirements of the Internal Revenue Code.</FONT></TD>
1771
</TR>
1772
</TABLE>
1773
<BR>
1774
1775
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1776
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1777
<TR VALIGN=TOP>
1778
<TD WIDTH=5%><FONT SIZE="3"><B>9.</B></FONT> </TD>
1779
<TD WIDTH=95%><FONT SIZE="3"><B>Net
1780
Assets Transferred from Other Plans</B></FONT></TD>
1781
</TR>
1782
</TABLE>
1783
<BR>
1784
1785
1786
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1787
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1788
<TR VALIGN=TOP>
1789
<TD WIDTH=5%>&nbsp;</TD>
1790
<TD WIDTH=95%><FONT SIZE=3>
1791
During fiscal years 2001, 2000 and 1999 the Company acquired or merged with
1792
various companies, including Arterial Vascular Engineering, Inc., Sofamor Danek
1793
Group, Inc., Xomed Surgical Products, Inc. and AVECOR Cardiovascular, Inc. In
1794
connection with these mergers and acquisitions, $6.4 million and $52.1 million
1795
of benefit plan assets were transferred into the Plan during fiscal years 2001
1796
and 2000, respectively.</FONT></TD>
1797
</TR>
1798
</TABLE>
1799
<BR>
1800
1801
1802
1803
<!-- MARKER FORMAT-SHEET="Para Hang" -->
1804
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1805
<TR VALIGN=TOP>
1806
<TD WIDTH=5%>&nbsp;</TD>
1807
<TD WIDTH=95%><FONT SIZE=3>
1808
During
1809
fiscal years 2001 and 2000, participants transferred assets from the Medtronic,
1810
Inc. Employees Stock Ownership Plan into the Plan of $3.2 million and $5.9 million,
1811
respectively.</FONT></TD>
1812
</TR>
1813
</TABLE>
1814
<BR><BR><BR><BR>
1815
1816
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1817
<P ALIGN="CENTER">10</P>
1818
1819
1820
1821
1822
1823
1824
<PAGE>
1825
1826
1827
<BR><BR><BR><BR><BR>
1828
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
1829
<P ALIGN="CENTER"><B>SUPPLEMENTAL SCHEDULE</B></P>
1830
1831
1832
1833
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
1834
<P ALIGN="CENTER">11</P>
1835
1836
1837
1838
1839
1840
1841
<PAGE>
1842
1843
1844
1845
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
1846
<P><FONT SIZE="3"><B>Medtronic, Inc. and Participating Employers Supplemental<BR> Retirement Plan<BR>
1847
Schedule of Assets Held for Investment Purposes<BR>
1848
April 30, 2001<BR>
1849
(in 000&#146;s)</B></FONT> </P>
1850
1851
1852
<HR SIZE=2 WIDTH=100%>
1853
<BR>
1854
1855
<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="700">
1856
<TR VALIGN="BOTTOM">
1857
<TH COLSPAN="2" ALIGN="LEFT"><FONT SIZE="-1">(a)<BR>&nbsp;</FONT></TH>
1858
<TH COLSPAN="2"><FONT SIZE="-1">(b)<BR>Fund</FONT></TH>
1859
<TH COLSPAN="2"><FONT SIZE="-1">(c)<BR>Investment Type</FONT></TH>
1860
<TH COLSPAN="2"><FONT SIZE="-1">(d)<BR>Cost**</FONT></TH>
1861
<TH COLSPAN="2"><FONT SIZE="-1">(e)<BR>Current Value</FONT></TH></TR>
1862
<TR VALIGN="BOTTOM">
1863
<TD WIDTH="5%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1864
<TD WIDTH="1%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1865
<TD WIDTH="39%" ALIGN="LEFT"><FONT SIZE="-1">Medtronic Common Stock Fund</FONT></TD>
1866
<TD WIDTH="1%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1867
<TD WIDTH="28%" ALIGN="LEFT"><FONT SIZE="-1">Company Stock Fund</FONT></TD>
1868
<TD WIDTH="2%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1869
<TD WIDTH="8%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1870
<TD WIDTH="1%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1871
<TD WIDTH="12%" ALIGN="RIGHT"><FONT SIZE="-1">$&nbsp;&nbsp;&nbsp;614,016</FONT></TD>
1872
<TD WIDTH="1%" ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1873
<TR VALIGN="BOTTOM">
1874
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1875
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard 500 Index Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1876
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1877
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1878
<TD ALIGN="RIGHT"><FONT SIZE="-1">130,136</FONT></TD>
1879
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1880
<TR VALIGN="BOTTOM">
1881
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1882
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard PRIMECAP Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1883
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1884
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1885
<TD ALIGN="RIGHT"><FONT SIZE="-1">115,104</FONT></TD>
1886
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1887
<TR VALIGN="BOTTOM">
1888
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1889
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard Wellington Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1890
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1891
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1892
<TD ALIGN="RIGHT"><FONT SIZE="-1">97,555</FONT></TD>
1893
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1894
<TR VALIGN="BOTTOM">
1895
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1896
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard Windsor II Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1897
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1898
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1899
<TD ALIGN="RIGHT"><FONT SIZE="-1">53,331</FONT></TD>
1900
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1901
<TR VALIGN="BOTTOM">
1902
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1903
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard Explorer Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1904
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1905
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1906
<TD ALIGN="RIGHT"><FONT SIZE="-1">34,712</FONT></TD>
1907
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1908
<TR VALIGN="BOTTOM">
1909
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1910
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard International Growth Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1911
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1912
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1913
<TD ALIGN="RIGHT"><FONT SIZE="-1">28,652</FONT></TD>
1914
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1915
<TR VALIGN="BOTTOM">
1916
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1917
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard U.S. Growth Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1918
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1919
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1920
<TD ALIGN="RIGHT"><FONT SIZE="-1">23,401</FONT></TD>
1921
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1922
<TR VALIGN="BOTTOM">
1923
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1924
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard Total Bond Market Index Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1925
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1926
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1927
<TD ALIGN="RIGHT"><FONT SIZE="-1">17,325</FONT></TD>
1928
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1929
<TR VALIGN="BOTTOM">
1930
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1931
<TD ALIGN="LEFT"><FONT SIZE="-1">Vanguard Extended Market Index Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1932
<TD ALIGN="LEFT"><FONT SIZE="-1">Registered Investment Company</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1933
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1934
<TD ALIGN="RIGHT"><FONT SIZE="-1">9,861</FONT></TD>
1935
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1936
<TR VALIGN="BOTTOM">
1937
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1938
<TD ALIGN="LEFT"><FONT SIZE="-1">Participant Loans</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1939
<TD ALIGN="LEFT"><FONT SIZE="-1">Interest at 6.10% to 11% (Repayment</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1940
<TR VALIGN="BOTTOM">
1941
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1942
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1943
<TD ALIGN="LEFT"><FONT SIZE="-1">period is one to five years)</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1944
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1945
<TD ALIGN="RIGHT"><FONT SIZE="-1">14,270</FONT></TD>
1946
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1947
<TR VALIGN="BOTTOM">
1948
<TD ALIGN="LEFT"><FONT SIZE="-1">*</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1949
<TD ALIGN="LEFT"><FONT SIZE="-1">Medtronic Interest Income Fund</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1950
<TD ALIGN="LEFT"><FONT SIZE="-1">Unallocated Insurance Contracts</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1951
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1952
<TD ALIGN="RIGHT"><FONT SIZE="-1">149,718</FONT></TD>
1953
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1954
<TR>
1955
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1956
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1957
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1958
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1959
<TD COLSPAN="2"><HR NOSHADE COLOR="Black" SIZE="1"></TD></TR>
1960
<TR VALIGN="BOTTOM">
1961
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1962
<TD ALIGN="LEFT"><FONT SIZE="-1">Totals</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1963
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1964
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD><TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD>
1965
<TD ALIGN="RIGHT"><FONT SIZE="-1">$1,288,081</FONT></TD>
1966
<TD ALIGN="LEFT"><FONT SIZE="-1">&nbsp;</FONT></TD></TR>
1967
<TR>
1968
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1969
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1970
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1971
<TH COLSPAN="2"><FONT SIZE="-1"></FONT></TH>
1972
<TD COLSPAN="2"><HR NOSHADE COLOR="Black" SIZE="2"></TD></TR>
1973
</TABLE>
1974
<BR>
1975
1976
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1977
<TR VALIGN=TOP>
1978
<TD WIDTH=5%><FONT SIZE=3>&nbsp;</FONT></TD>
1979
<TD WIDTH=95%><FONT SIZE=3>The above
1980
data was prepared from information certified as complete and accurate by The Vanguard
1981
Fiduciary Trust Company, the Plan&#146;s Trustee.</FONT></TD>
1982
</TR>
1983
</TABLE>
1984
<BR>
1985
1986
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1987
<TR VALIGN=TOP>
1988
<TD WIDTH=5%><FONT SIZE=3>* </FONT></TD>
1989
<TD WIDTH=95%><FONT SIZE=3>Denotes
1990
party-in-interest.</FONT></TD>
1991
</TR>
1992
</TABLE>
1993
<BR>
1994
1995
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0>
1996
<TR VALIGN=TOP>
1997
<TD WIDTH=5%><FONT SIZE=3>** </FONT></TD>
1998
<TD WIDTH=95%><FONT SIZE=3>Cost information
1999
is excluded as it is no longer required for participant-directed investments. </FONT></TD>
2000
</TR>
2001
</TABLE>
2002
2003
<!-- MARKER FORMAT-SHEET="Page Breaks" -->
2004
<P ALIGN="CENTER">12</P>
2005
2006
2007
2008
2009
2010
<PAGE>
2011
2012
<!-- MARKER FORMAT-SHEET="Para Center Bold" -->
2013
<P ALIGN="CENTER"><B>Consent of Independent Accountants</B></P>
2014
2015
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
2016
<P><FONT SIZE=3>We hereby consent to the incorporation by reference in the
2017
Registration Statements on Form S-8 (Nos.&nbsp;33-37529 and 33-44230) of
2018
Medtronic, Inc. of our report dated September 28, 2001 relating to the financial
2019
statements of the Medtronic, Inc. and Participating Employers Supplemental
2020
Retirement Plan which appears on this Form 11-K. </FONT></P>
2021
<BR><BR><BR><BR>
2022
2023
2024
<!-- MARKER FORMAT-SHEET="Para Flush In 0" -->
2025
<P><FONT SIZE=3>/s/ PricewaterhouseCoopers LLP<BR>
2026
PricewaterhouseCoopers LLP<BR>
2027
Minneapolis, Minnesota<BR>
2028
October 24, 2001 </FONT></P>
2029
2030
</BODY>
2031
</HTML>
2032
2033
</TEXT>
2034
</DOCUMENT>
2035
</SEC-DOCUMENT>
2036
2037